Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | GILD | INCY |
|---|
| Close | 147.68 | 124.75 |
| Market Cap | $183B | $25.3B |
| 1M | +6.31% | +1.01% |
| P/E (TTM) | — | 15.3 |
| Forward P/E | 25.3 | 18.1 |
| P/E 5-Yr Percentile | — | 8 |
| P/S | 6.0 | 4.2 |
| P/B | 15.3 | 3.9 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $7.8B | $1.3B |
| Revenue YoY | +10.2% | +20.9% |
| Gross Margin | 79.8% | 91.8% |
| Latest Quarter EPS | -8.45 | 1.47 |
| Avg Post-Earnings Move | ±3.8% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 0.00% |
| 90-Day Net Insider Buying | −$15.4M | −$15.4M |
GILD · Revenue, Last 8 Quarters ($B)
INCY · Revenue, Last 8 Quarters ($B)
